August 2025: Teva Pharmaceuticals launched the first FDA-approved generic of Saxenda (liraglutide injection) in the United States, expanding lower-cost options for prescribers
Instead of receiving all your vitamin needs from multiple food sources and pills, you receive the optimal cocktail of vitamins and minerals straight into your bloodstream
This selective targeting strategy represents a precision-based approach to senolysis, focusing on restoring intrinsic apoptosis rather than inducing external stress
Amongst the approved ICI agents, anti-PD1 agents have the largest indication across several tumours, including metastatic non-small cell lung cancer (NSCLC) [4], advanced head and neck cancer (HNC) [5], advanced melanoma [6], genitourinary tumours and others [7, 8]
Nanotechnology offers novel opportunities for targeted ferroptosis modulation in RA therapy [14]